#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alpha-1 antitrypsin deficiency Duchenne muscular dystrophy Leiomyosarcoma Lymphatic malformation Leukaemia Cutaneous T-cell lymphoma stage I Immunodeficiency common variable Activated PI3 kinase delta syndrome Marfan's syndrome Encephalitis autoimmune Ovarian cancer stage III Laryngeal squamous cell carcinoma Adenoid cystic carcinoma Hepatic cirrhosis Haemophilia B with anti factor IX More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Krabbe’s disease – Trials in Disease Progressive multifocal leukoencephalopathy – Life with Disease Mucopolysaccharidosis – Trials in Disease Lennox-Gastaut syndrome – Basic Information Rhabdomyosarcoma – Life with Disease Isodicentric chromosome 15 syndrome – Life with Disease Mantle cell lymphoma stage III – Trials in Disease Hereditary optic atrophy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iti-1284 Pentetic Acid E.coli Polysaccharide Revumenib M2Rlab Kbp-336 Triptorelin Pamoate Canis Familiaris (553) Vinorelbine Tartrate Tirzepatide Tacrolimus Monohydrate Setrusumab Polydextrose Follitropin Delta Emedastine Simvastatin Mecillinam Apg777 Nelivaptan Furosemide More therapies…

    Learn about Your Condition

    Hyperoxaluria Rectal cancer stage III Wolfram syndrome Neonatal hyperglycaemia Tumour of ampulla of Vater Osteogenesis imperfecta Conjunctivitis allergic Solitary fibrous tumour Macular degeneration Neck pain Colitis Vertigo Pulmonary fibrosis Pulmonary venous thrombosis Retroperitoneal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Evangelismos S.A.

Evangelismos S.A.

Ipsiladou 45-47, Athens, 106 76, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study of isatuximab, belantamab mafodotin and dexamethasone combination for patients with relapsed or refractory multiple myeloma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Belantamab Mafodotin
    • Dexamethasone
    • Isatuximab
    Greece Italy Norway

  • Study Comparing Selinexor, Pomalidomide, and Dexamethasone with Elotuzumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    • Selinexor
    • Dexamethasone
    France Germany Greece Italy The Netherlands Spain

  • Study on Tulisokibart for Treating Moderate to Severe Crohn’s Disease in Adults

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Tulisokibart
    Austria Belgium Croatia Czechia Denmark Finland +15

  • Study on the Risk of Tumor Lysis Syndrome in Adults with Untreated Chronic Lymphocytic Leukemia Using Venetoclax, Obinutuzumab, or Acalabrutinib

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Obinutuzumab
    • Venetoclax
    France Greece Spain

  • Study on the Safety and Effectiveness of Zilovertamab Vedotin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Zilovertamab Vedotin
    Czechia Estonia France Greece Italy Norway +3

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Asundexian
    • Apixaban
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Belgium Bulgaria Czechia France Greece +8
Previous Page
1 … 12 13 14

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!